November 1, 2017 — The double kissing (DK) crush two-stent technique was associated with a lower rate of target lesion ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents.
October 31, 2017 – Thirty-day results from ABSORB IV, the largest randomized everolimus-eluting bioresorbable vascular ...
October 31, 2017 — The U.S. Food and Drug Administration (FDA) issued a warning to healthcare providers that interim ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
October 27, 2017 — CeloNova BioSciences Inc. announced the U.S. Food and Drug Administration (FDA) approved expansion of ...
October 25, 2017 — Elixir Medical Corp. announced it will unveil a new metallic drug-eluting stent (DES) platform at ...
October 25, 2017 — Amaranth Medical will provide an update at the annual Transcatheter Cardiovascular Therapeutics (TCT) ...
October 2, 2017 — Here is the list of the most popular articles and videos on the Diagnostic and Interventional ...
September 22, 2017 — Physicians demonstrated that reducing metal burden in superficial femoral artery (SFA) therapy ...
September 21, 2017 — Cardinal Health and Tryton Medical Inc. announced that the Tryton coronary Side Branch Stent was ...
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials ...
September 11, 2017 — Veniti Inc. announced that Boston Scientific will distribute the Vici Venous Stent under a limited ...
September 8, 2017 — Abbott Vascular has announced it will end commercial sales of its Absorb bioresorbable vascular ...
September 1, 2017 — Biotronik recently announced data from the BIOFLOW-V randomized trial comparing Orsiro and Xience dr ...
August 18, 2017 — Medtronic plc announced a global randomized clinical trial that will evaluate one-month dual ...
August 3, 2017 — Abbott recently announced the first patient has been enrolled in a clinical study evaluating the short ...